ATE500824T1 - Verfahren zur reinigung von trans-(-)-delta9- tetrahydrocannabinol und trans-(+)-delta9- tetrahydrocannabinol - Google Patents

Verfahren zur reinigung von trans-(-)-delta9- tetrahydrocannabinol und trans-(+)-delta9- tetrahydrocannabinol

Info

Publication number
ATE500824T1
ATE500824T1 AT05807597T AT05807597T ATE500824T1 AT E500824 T1 ATE500824 T1 AT E500824T1 AT 05807597 T AT05807597 T AT 05807597T AT 05807597 T AT05807597 T AT 05807597T AT E500824 T1 ATE500824 T1 AT E500824T1
Authority
AT
Austria
Prior art keywords
delta9
tetrahydrocannabinol
trans
purifying
purifying trans
Prior art date
Application number
AT05807597T
Other languages
English (en)
Inventor
Arie Gutman
Gennady Nisnevich
Igor Rukhman
Boris Tishin
Marina Etinger
Irina Fedotev
Boris Pertsikov
Ram Khanolkar
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35789123&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE500824(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE500824T1 publication Critical patent/ATE500824T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
AT05807597T 2004-11-22 2005-11-18 Verfahren zur reinigung von trans-(-)-delta9- tetrahydrocannabinol und trans-(+)-delta9- tetrahydrocannabinol ATE500824T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63055604P 2004-11-22 2004-11-22
PCT/EP2005/012378 WO2006053766A1 (en) 2004-11-22 2005-11-18 Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
ATE500824T1 true ATE500824T1 (de) 2011-03-15

Family

ID=35789123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05807597T ATE500824T1 (de) 2004-11-22 2005-11-18 Verfahren zur reinigung von trans-(-)-delta9- tetrahydrocannabinol und trans-(+)-delta9- tetrahydrocannabinol

Country Status (30)

Country Link
US (6) US8383842B2 (de)
EP (3) EP2356987B1 (de)
JP (3) JP4995728B2 (de)
KR (1) KR100919719B1 (de)
CN (2) CN102151259A (de)
AR (1) AR054989A1 (de)
AT (1) ATE500824T1 (de)
AU (2) AU2005305944B2 (de)
BR (1) BRPI0519803A2 (de)
CA (2) CA2921590C (de)
CY (1) CY1111471T1 (de)
DE (1) DE602005026852D1 (de)
DK (3) DK2289509T3 (de)
EA (1) EA012299B1 (de)
ES (3) ES2362288T3 (de)
HR (3) HRP20110385T1 (de)
HU (2) HUE027197T2 (de)
IL (1) IL183306A (de)
ME (2) ME02306B (de)
MX (1) MX2007006104A (de)
NO (1) NO331831B1 (de)
NZ (1) NZ556038A (de)
PL (3) PL1824475T3 (de)
PT (2) PT1824475E (de)
RS (3) RS54338B1 (de)
SI (3) SI2356987T1 (de)
TW (2) TWI369203B (de)
UA (1) UA88491C2 (de)
WO (1) WO2006053766A1 (de)
ZA (1) ZA200706837B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI369203B (en) * 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
TWI366460B (en) * 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
ZA200802767B (en) 2005-09-29 2009-09-30 Amr Technology Inc Process for production of delta-9-tetrahydrocannabinol
US8039509B2 (en) 2006-11-10 2011-10-18 Johnson Matthey Public Limited Company Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
US8980940B2 (en) 2006-11-10 2015-03-17 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
GB0702895D0 (en) * 2007-02-14 2007-03-28 Resolution Chemicals Ltd Delta 9 tetrahydrocannabinol derivatives
GB0703284D0 (en) * 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
WO2009099868A1 (en) * 2008-02-06 2009-08-13 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
US10624859B2 (en) 2012-08-20 2020-04-21 Rhodes Technologies Systems and methods for increasing stability of dronabinol compositions
AU2015280412B2 (en) 2014-06-26 2018-07-26 Island Breeze Systems Ca, Llc MDI related products and methods of use
US10155708B2 (en) 2015-01-22 2018-12-18 Phytoplant Research S.L. Methods of purifying cannabinoids, compositions and kits thereof
US11034639B2 (en) 2015-01-22 2021-06-15 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
US10207198B2 (en) 2015-01-22 2019-02-19 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
CN106268657A (zh) * 2015-05-14 2017-01-04 株式会社大赛璐 光学异构体用分离剂
US20170008869A1 (en) * 2015-07-10 2017-01-12 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
EP3455213B1 (de) * 2016-05-13 2021-11-24 Symrise AG Verfahren für die reinigung von cannabinoide verbindungen durch simulierte chromatographie im fliessbett
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
US10399920B2 (en) 2016-06-01 2019-09-03 S&B Pharma, Inc. Crystalline form of cannabidiol
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
CN106810426B (zh) * 2016-12-29 2020-05-08 暨明医药科技（苏州）有限公司 一种大麻二酚的合成方法
US11213558B2 (en) 2017-05-17 2022-01-04 Orochem Technologies, Inc. CBX extraction-isolation process
US10189762B1 (en) * 2017-07-07 2019-01-29 Orochem Technologies, Inc. Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
SG11202001725SA (en) * 2017-09-01 2020-03-30 Pureform Global Inc Synthetic cannabidiol compositions and methods of making the same
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
US11192870B2 (en) 2018-03-07 2021-12-07 Socati Technologies—Oregon, Llc Continuous isolation of cannabidiol and conversion of cannabidiol to delta 8-tetrahydrocannabinol and delta 9-tetrahydrocannabinol
US11851415B2 (en) 2018-03-07 2023-12-26 Cleen Technology Inc. Continuous isolation of cannabidiol and cannabinoids and conversion of cannabidiol to delta 8-tetrahydrocannabinol and delta 9-tetrahydrocannabinol
MX2020009335A (es) * 2018-03-07 2020-12-03 Socati Tech Oregon Llc Aislamiento continuo de cannabidiol y conversion de cannabidiol a delta 8-tetrahidro cannabinol y delta 9- tetrahidro cannabinol.
US11485700B2 (en) * 2018-06-28 2022-11-01 Symrise Ag Synthesis of (+)-cannabinoids and their therapeutic effects
WO2020028198A1 (en) 2018-08-03 2020-02-06 Biomass Oil Separation Solutions, Llc Processes and apparatus for extraction of substances and enriched extracts from plant material
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
EP3873459A1 (de) 2018-10-31 2021-09-08 Enantia, S.L. Feste zusammensetzungen aus co-kristallen von cannabinoiden
EP3653596A1 (de) 2018-11-14 2020-05-20 Indena S.p.A. Kontinuierliche flusssynthese von cannabidiol
CN109734554B (zh) * 2019-02-25 2021-11-23 江苏暨明医药科技有限公司 一种反式-薄荷基-2,8-二烯-1-醇的合成工艺
CN111943813B (zh) * 2019-05-17 2023-04-14 上海特化医药科技有限公司 大麻二酚类化合物的制备方法
WO2020248062A1 (en) * 2019-06-11 2020-12-17 Canopy Growth Corporation Improved methods for cannabinoid isomerization
US20220235023A1 (en) 2019-06-11 2022-07-28 Canopy Growth Corporation Improved methods for converting cannabidiol into delta8-tetrahydrocannabinol
US10799546B1 (en) 2019-07-26 2020-10-13 Biomass Oil Separation Solutions, Llc Modular, integrated process and apparatus for extracting, refining and remediating active substances from plant material
US11542243B1 (en) 2019-09-26 2023-01-03 FusionFarms, LLC Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
IL292377B2 (en) * 2019-10-21 2023-11-01 Esolate Ltd Thin compounds and their production
GB2588456B (en) * 2019-10-25 2023-02-01 Gw Res Ltd Cannabinoid compound
GB2588457B (en) * 2019-10-25 2022-12-21 Gw Res Ltd Cannabinoid compound
GB2588455B (en) * 2019-10-25 2022-12-21 Gw Res Ltd Cannabinoid compound
EP3923917B1 (de) 2020-03-12 2026-03-04 Council of Scientific & Industrial Research, an Indian registered body incorporated under the Registration of Societies Act (Act XXI of 1860) Verfahren zur synthese von cannabidiol und dessen zwischenprodukten
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
WO2022125966A1 (en) 2020-12-10 2022-06-16 Orochem Technologies Inc. Process for removing thc from cannabinoids
CN113336705B (zh) * 2021-08-09 2021-12-10 中国农业科学院农产品加工研究所 一种大麻二酚-2-咪唑-1-甲酸酯及其应用
WO2024028516A1 (en) 2022-08-05 2024-02-08 Salud & Semillas, S.L. CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl3 * 6H2O AS CATALYST
CN115583933B (zh) * 2022-10-31 2024-02-06 暨明医药科技（苏州）有限公司 一种高纯度四氢大麻素同系物的制备方法
CN115784836A (zh) * 2022-12-08 2023-03-14 南京康立瑞生物科技有限公司 一种高选择性的制备反式-薄荷基-2,8-二烯-1-醇的方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
CH481911A (de) 1967-05-19 1969-11-30 Theodor Dr Petrzilka Verfahren zur Herstellung von tricyclischen Verbindungen
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3668224A (en) * 1970-07-02 1972-06-06 Theodor Petrzilka PROCESS OF PRODUCING 6a, 10a-TRANS-6a,7,8,10a-TETRAHYDRODIBENZO (b,d)-PYRANS
US4025516A (en) * 1975-06-23 1977-05-24 The John C. Sheehan Institute For Research, Inc. Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans
US4381399A (en) * 1981-12-21 1983-04-26 Aerojet-General Corporation Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
US4970075A (en) * 1986-07-18 1990-11-13 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
DE4100441A1 (de) * 1991-01-09 1992-07-16 Mack Chem Pharm Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol
US6703418B2 (en) * 1991-02-26 2004-03-09 Unimed Pharmaceuticals, Inc. Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection
US5389375A (en) 1993-05-21 1995-02-14 University Of Mississippi Stable suppository formulations effecting bioavailability of Δ9 -thc
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1996041626A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US6328992B1 (en) * 1997-03-03 2001-12-11 Lawrence L. Brooke Cannabinoid patch and method for cannabis transdermal delivery
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
US20020039795A1 (en) 1998-10-26 2002-04-04 Elsohly Et Al Method of preparing delta-9-tetrahydrocannabinol
US6730519B2 (en) 1998-10-26 2004-05-04 The University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
FI990915A0 (fi) * 1999-04-23 1999-04-23 Orion Yhtymae Oyj Jauheinhalaattori
US6403126B1 (en) * 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6747058B1 (en) * 1999-08-20 2004-06-08 Unimed Pharmaceuticals, Inc. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
US6620351B2 (en) * 2000-05-24 2003-09-16 Auburn University Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer
GB2368061B (en) * 2000-10-20 2005-05-11 Gw Pharmaceuticals Ltd Dose dispensing apparatus
EP2283829A1 (de) * 2000-10-30 2011-02-16 Euro-Celtique S.A. Hydrocodon-Formulierungen mit gesteuerter Freisetzung
US6730330B2 (en) * 2001-02-14 2004-05-04 Gw Pharma Limited Pharmaceutical formulations
CH695661A5 (de) * 2001-03-06 2006-07-31 Forsch Hiscia Ver Fuer Krebsfo Pharmazeutische Zusammensetzung.
EP1409473A2 (de) * 2001-03-07 2004-04-21 Websar Innovations Inc. Umsetzung von cbd in delta-8-thc und delta-9-thc
US20030050334A1 (en) * 2001-04-30 2003-03-13 Murty Ram B. Process for extraction of Delta-9-Tetrahydrocannabinol and other related cannabinoids and preparation of specific strength marijuana cigarettes
GB0112752D0 (en) * 2001-05-25 2001-07-18 Johnson Matthey Plc Synthesis of cannabinoids
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
CA2474951A1 (en) * 2002-02-01 2003-08-07 Resolution Chemicals Limited Production of .delta.9 tetrahydrocannabinol
AU2002242779A1 (en) 2002-02-21 2003-09-09 Timothee Biel Device for driving motor vehicles, in particular with hybrid propulsion
UA79281C2 (en) * 2002-04-03 2007-06-11 Solvay Pharm Bv Stabilized composition comprising a natural cannabinoid compound and process for the preparation thereof
US6946150B2 (en) * 2002-08-14 2005-09-20 Gw Pharma Limited Pharmaceutical formulation
GB0222077D0 (en) 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
CN100455576C (zh) 2002-11-12 2009-01-28 马林克罗特公司 大麻素的结晶衍生物及大麻素的纯化方法
US20040229939A1 (en) * 2003-02-14 2004-11-18 Chowdhury Dipak K. Tetrahydrocannabinol compositions and methods of manufacture and use thereof
BRPI0416268A (pt) 2003-11-05 2007-12-11 Unimed Pharmaceuticals Inc composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
GB0329635D0 (en) * 2003-12-23 2004-01-28 Johnson Matthey Plc Process for purifying trans-tetrahydrocannabinol
CA2573859A1 (en) * 2004-07-19 2006-01-26 Cilag Ltd. Method for obtaining pure tetrahydrocannabinol
GB0425445D0 (en) * 2004-11-18 2004-12-22 Smithkline Beecham Corp Novel compositions
TWI369203B (en) * 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
TWI366460B (en) * 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
ES2534900T3 (es) 2007-07-30 2015-04-30 Zynerba Pharmaceuticals, Inc. Profármacos de cannabidiol, composiciones que comprenden los profármacos de cannabidiol y métodos de uso de los mismos
US8642645B2 (en) * 2011-05-20 2014-02-04 Brooks Kelly Research, LLC. Pharmaceutical composition comprising Cannabinoids

Also Published As

Publication number Publication date
SI1824475T1 (sl) 2011-06-30
TW200633695A (en) 2006-10-01
EP2289509A2 (de) 2011-03-02
AU2005305944B2 (en) 2010-03-04
EP2356987B1 (de) 2016-01-06
US9744151B2 (en) 2017-08-29
MX2007006104A (es) 2007-07-11
CN101076329A (zh) 2007-11-21
NO20072964L (no) 2007-08-17
CA2587957A1 (en) 2006-05-26
SI2356987T1 (sl) 2016-04-29
WO2006053766A1 (en) 2006-05-26
US8383842B2 (en) 2013-02-26
RS54338B1 (sr) 2016-02-29
EA200701123A1 (ru) 2007-12-28
UA88491C2 (ru) 2009-10-26
HK1154796A1 (en) 2012-05-04
ES2566480T3 (es) 2016-04-13
CA2921590A1 (en) 2006-05-26
RS54537B1 (sr) 2016-06-30
CA2587957C (en) 2016-05-03
DK2356987T3 (en) 2016-03-21
EP2289509B1 (de) 2015-10-14
SI2289509T1 (sl) 2016-01-29
RS51706B (sr) 2011-10-31
PL2356987T3 (pl) 2016-09-30
EP1824475B1 (de) 2011-03-09
JP2008101000A (ja) 2008-05-01
DK1824475T3 (da) 2011-06-06
HRP20110385T1 (hr) 2011-06-30
PL1824475T3 (pl) 2011-09-30
JP2012180350A (ja) 2012-09-20
ME02306B (me) 2016-06-20
HUE027197T2 (en) 2016-10-28
DE602005026852D1 (de) 2011-04-21
US20160184261A1 (en) 2016-06-30
HRP20160300T1 (hr) 2016-04-22
PL2289509T3 (pl) 2016-04-29
US9675581B2 (en) 2017-06-13
US20130171259A1 (en) 2013-07-04
US20150126596A1 (en) 2015-05-07
NZ556038A (en) 2009-12-24
CN102151259A (zh) 2011-08-17
EP2289509A3 (de) 2011-08-10
CA2921590C (en) 2019-09-24
ME02403B (me) 2016-09-20
KR20070086529A (ko) 2007-08-27
TWI436991B (zh) 2014-05-11
JP5048448B2 (ja) 2012-10-17
HRP20151301T1 (hr) 2016-01-01
EP2356987A1 (de) 2011-08-17
CY1111471T1 (el) 2015-08-05
AR054989A1 (es) 2007-08-01
EA012299B1 (ru) 2009-08-28
EP1824475A1 (de) 2007-08-29
US9278083B2 (en) 2016-03-08
WO2006053766A8 (en) 2006-12-14
TWI369203B (en) 2012-08-01
ZA200706837B (en) 2008-04-30
HK1159500A1 (en) 2012-08-03
AU2010200227A1 (en) 2010-02-11
AU2005305944A1 (en) 2006-05-26
PT1824475E (pt) 2011-06-01
PT2289509E (pt) 2015-12-23
IL183306A (en) 2012-06-28
DK2289509T3 (en) 2015-11-23
US20090298930A1 (en) 2009-12-03
IL183306A0 (en) 2007-09-20
KR100919719B1 (ko) 2009-10-06
JP4995728B2 (ja) 2012-08-08
JP2008520608A (ja) 2008-06-19
US8937097B2 (en) 2015-01-20
ES2362288T3 (es) 2011-06-30
TW201302722A (zh) 2013-01-16
NO331831B1 (no) 2012-04-16
US20160184260A1 (en) 2016-06-30
US20160199344A1 (en) 2016-07-14
BRPI0519803A2 (pt) 2009-03-17
HUE025904T2 (en) 2016-05-30
ES2556802T3 (es) 2016-01-20
CN101076329B (zh) 2011-08-10
HK1109058A1 (en) 2008-05-30

Similar Documents

Publication Publication Date Title
DE602005026852D1 (de) Verfahren zur reinigung von trans-(-)-delta9-tetrahydrocannabinol und trans-(+)-delta9-tetrahydrocannabinol
DE602005017537D1 (de) Verfahren und System zur Fahrunterstützung
DE602006013180D1 (de) Verfahren und system zur reduzierung von verbindungslatenzen
DE602005015473D1 (de) Verfahren und mittel zur herstellung von hyaluronan
DE602004002618D1 (de) Verfahren und System zur Kantenhervorhebung
EP1869573A4 (de) Systeme und verfahren zur implementierung von mehrzwecklaschen und laschensätze
EP1723571A4 (de) Verfahren und vorrichtungen zur datenanalyse
EP1736231A4 (de) Vorrichtung und verfahren zur gewinnung von co2
DE602006010154D1 (de) Biometrisches System und biometrisches Verfahren
DE602004029760D1 (de) System und Verfahren zur Datenmigration
EP1905443A4 (de) Flüssigkeit zur prävention von gewebeadhäsion und verfahren zur verhinderung von gewebeadhäsion
DE602005022123D1 (de) Vorrichtung und verfahren zur beförderung von bohrklein
DE602005014371D1 (de) Einrichtung und verfahren zur unabhängigen positionierung
DE602004019622D1 (de) System und Verfahren zur Benutzerunterstützung
DE602006021341D1 (de) Rauchgasnassentschwefelungsvorrichtung und verfahren zur rauchgasnassentschwefelung
DE602005001520D1 (de) Zeiteinstellungssystem und Zeiteinstellungsverfahren
DE602006004529D1 (de) Verfahren und Vorrichtung zur Kontrolle von Objekten
DE602006008098D1 (de) Verfahren und System zur Verwaltung von Datenverkehr
DE602004018421D1 (de) Rufzulassungssteuerung und Verfahren zur Rufzulassungssteuerung
DE602006015182D1 (de) Zusammensetzung und verfahren zur kontrolle von insekten
DE602006001222D1 (de) System und Verfahren zur Patientenpositionierung
ATE461919T1 (de) Verfahren zur herstellung von montelukast und zwischenprodukte dafür
DE602004031104D1 (de) Informationsprozessor und Verfahren zur Multi-Hit Kontrolle
DE602005025615D1 (de) Computersystem, computerprogramm und verfahren zur addition
ATE406372T1 (de) Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1824475

Country of ref document: EP